172
Participants
Start Date
June 30, 2013
Primary Completion Date
November 30, 2017
Study Completion Date
August 31, 2022
Spiration Valve System
Subjects assigned to the treatment group will undergo a bronchoscopic procedure to have valves placed in the most diseased lobe of the lung to occlude all segments of the lobe.
Medical Management
Stable management is based on the ACP/ACCP/ATS/ERS Guidelines for Management of Stable COPD. Medical management will include management of COPD medications, oxygen use, and pulmonary rehabilitation.
Cornell NYPH, New York
University of Pittsburgh Medical Center, Pittsburgh
Penn State Milton S. Hershey Medical Center, Hershey
Temple University Hospital, Philadelphia
University of Maryland, Baltimore
Virginia Commonwealth University, Richmond
Carolinas Medical Center, Charlotte
Piedmont Hospital, Atlanta
Mayo Clinic Jacksonville, Jacksonville
Miami VA Healthcare System, Miami
Tampa General Hospital, Tampa
Sarasota Memorial Hospital, Sarasota
Vanderbilt University Medical Center, Nashville
University of Tennessee Medical Center, Knoxville
University of Cincinnati, Cincinnati
Beaumont Botsford Hospital (DCRC), Farmington Hills
Medical College of Wisconsin, Milwaukee
University of Chicago, Chicago
Northwestern Memorial Hospital, Chicago
Louisiana State University Hospital, Shreveport
Sparks Regional Medical Center, Fort Smith
UT Southwestern Medical Center at Dallas, Dallas
Michael DeBakey VA Medical Center, Houston
University of Utah, Salt Lake City
University of California San Diego, San Diego
Kaiser Permanente Riverside Medical Center, Riverside
California Pacific Medical Center, San Francisco
Kaiser Permanente Northwest Medical Center, Clackamas
Beth Israel Deaconess Medical Center, Boston
Lahey Clinic, Burlington
Cooper University Hospital, Camden
Fletcher Allen Medical Center, Burlington
University of Calgary, Calgary
Laval University, Québec
Olympus Corporation of the Americas
INDUSTRY